These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9690412)

  • 1. Anaemia in dialysis patients as a side-effect of sartanes.
    Schwarzbeck A; Wittenmeier KW; Hällfritzsch U
    Lancet; 1998 Jul; 352(9124):286. PubMed ID: 9690412
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study Investigators.
    Kassler-Taub K; Littlejohn T; Elliott W; Ruddy T; Adler E
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):445-53. PubMed ID: 9607383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Irbesartan induced acute hepatitis: one case].
    Péron JM; Robic MA; Bureau C; Vinel JP
    Gastroenterol Clin Biol; 2005; 29(6-7):747-8. PubMed ID: 16149188
    [No Abstract]   [Full Text] [Related]  

  • 4. Brief report: acute renal failure after losartan treatment in a patient with bilateral renal artery stenosis.
    Holm EA; Randløv A; Strandgaard S
    Blood Press; 1996 Nov; 5(6):360-2. PubMed ID: 8973754
    [No Abstract]   [Full Text] [Related]  

  • 5. [Irbesartan].
    Caballero E; Sádaba B; Azanza JR; Honorato J
    Rev Med Univ Navarra; 1998; 42(3):166-9. PubMed ID: 10420939
    [No Abstract]   [Full Text] [Related]  

  • 6. Losartan and angina pectoris.
    Ahmad S
    Tex Heart Inst J; 1995; 22(4):347-8. PubMed ID: 8605440
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe anemia caused by the angiotensin receptor blocker irbesartan after renal transplantation.
    Simonetti GD; Bianchetti MG; Konrad M; von Vigier RO
    Pediatr Nephrol; 2007 May; 22(5):756-7. PubMed ID: 17216246
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversible ageusia associated with losartan.
    Schlienger RG; Saxer M; Haefeli WE
    Lancet; 1996 Feb; 347(8999):471-2. PubMed ID: 8618505
    [No Abstract]   [Full Text] [Related]  

  • 9. Irbesartan substitution for valsartan or losartan in treating hypertension.
    Graham MR; Allcock NM
    Ann Pharmacother; 2002 Dec; 36(12):1840-4. PubMed ID: 12452741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End-stage renal failure after irbesartan prescription in a diabetic patient with previously stable chronic renal insufficiency.
    Descombes E; Fellay G
    Ren Fail; 2000 Nov; 22(6):815-21. PubMed ID: 11104169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricemia and gout.
    Liberopoulos E; Christides D; Elisaf M
    J Hypertens; 2002 Feb; 20(2):347. PubMed ID: 11821722
    [No Abstract]   [Full Text] [Related]  

  • 12. Can angiotensin receptor antagonists be used safely in patients with previous ACE inhibitor-induced angioedema?
    Howes LG; Tran D
    Drug Saf; 2002; 25(2):73-6. PubMed ID: 11888349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Losartan--a new antihypertensive.
    Drug Ther Bull; 1995 Oct; 33(10):73-4. PubMed ID: 7493558
    [No Abstract]   [Full Text] [Related]  

  • 14. A new class of antihypertensive: angiotensin II receptor antagonists.
    McCoy R
    S D J Med; 1995 Sep; 48(9):319-20. PubMed ID: 7481726
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute renal failure after administration of losartan.
    Lamb RV; Walton T
    W V Med J; 1996; 92(5):241. PubMed ID: 8918197
    [No Abstract]   [Full Text] [Related]  

  • 16. An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan.
    Bunt T
    Clin Ther; 1999 Mar; 21(3):611-2. PubMed ID: 10321426
    [No Abstract]   [Full Text] [Related]  

  • 17. [Irbesartan: a new possibility in the treatment of hypertension].
    Rapi J
    Orv Hetil; 2002 May; 143(21):1187-92. PubMed ID: 12073539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy and safety of irbesartan and olmesartan in patients with hypertension (EARTH study).
    Morii J; Miura S; Shiga Y; Sugihara M; Arimura T; Sako H; Zhang B; Uehara Y; Saku K
    Clin Exp Hypertens; 2012; 34(5):342-9. PubMed ID: 22568596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension.
    Lee SE; Kim YJ; Lee HY; Yang HM; Park CG; Kim JJ; Kim SK; Rhee MY; Oh BH;
    Clin Ther; 2012 Mar; 34(3):552-568, 568.e1-9. PubMed ID: 22381711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irbesartan: a review of its use in hypertension and in the management of diabetic nephropathy.
    Croom KF; Curran MP; Goa KL; Perry CM
    Drugs; 2004; 64(9):999-1028. PubMed ID: 15101793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.